The possible reason is that isocitrate dehydrogenase inhibitor drugs induce terminal differentiation of AML cells by targeting IDH2 receptors, thereby inducing the production of chemokines in the lungs, leading to the migration, adhesion and infiltration of differentiated cells into the lungs and other tissues. The gene discussed is IDH3A; the disease is acute myeloid leukemia.